What are the paracrine signaling mechanisms of mesenchymal stem cells in atopic dermatitis?

Mesenchymal stem cells operate primarily through paracrine signaling—secreting growth factors, cytokines, and exosomes that modulate the cutaneous microenvironment. These bioactive molecules influence neighboring immune cells and keratinocytes to reduce Th2-driven inflammation, support skin barrier integrity, and promote natural repair processes without requiring MSC differentiation. Explanatory overview. Individual responses vary. Consult your physician.

How do MSCs modulate immune response and inflammation in eczematous skin?

MSCs exert immunomodulatory effects by shifting macrophages from pro-inflammatory (M1) to anti-inflammatory (M2) phenotypes, reducing pro-inflammatory cytokine production (TNF-α, IL-4, IL-13, IL-31), and promoting regulatory T-cell activity. This dynamic mechanism helps balance the inflammatory environment characteristic of atopic dermatitis, reducing pruritus and flare severity. Explanatory only. Not medical advice.

What is the observed biological response to MSC adjunctive therapy for atopic dermatitis?

Clinical observations indicate that many individuals experience reduction in skin inflammation and pruritus following MSC administration. The biological response involves decreased dermal infiltration of inflammatory cells, modulation of IgE-mediated pathways, and enhanced keratinocyte barrier function. Response duration depends on disease severity, age, lifestyle factors, and adherence to supportive nutritional and skincare approaches. Informational summary. Results vary.

How does MSC therapy support skin barrier homeostasis in eczema?

MSC-derived exosomes and paracrine factors upregulate filaggrin, loricrin, and other structural proteins essential for stratum corneum integrity. They also reduce transepidermal water loss by modulating tight junction proteins and supporting lipid synthesis in keratinocytes, thereby reinforcing the skin's natural barrier function. Explanatory mechanism overview. Research ongoing.

Atopic Dermatitis (Eczema): Mesenchymal Stem Cell Mechanisms & Adjunctive Support

The Integral Functional Regenerative Medicine Approach

A comprehensive three-tiered therapeutic strategy designed to address the multifactorial nature of atopic dermatitis through cellular, physical, and metabolic interventions.

Core Therapeutic Modalities

Our approach is built upon the principle that chronic inflammatory skin conditions require multimodal intervention. Umbilical cord mesenchymal stem cells serve as the foundational biological component, while physical therapy and nutritional medicine provide the essential supportive framework for optimal outcomes.

Cellular Immunomodulation Core

Umbilical cord-derived mesenchymal stem cells are utilized for their immunomodulatory properties. These cells, along with their derivatives (exosomes), are administered through minimally invasive techniques to engage with inflammatory pathways and support skin barrier repair.

Physical Medicine Integration

Customized supportive plans focus on stress reduction, lymphatic flow, and overall physiological balance. Physical medicine techniques support the body's regenerative capacity and complement the cellular therapy.

Nutritional Support

Nutritional medicine strategies are employed to reduce systemic inflammation, support skin barrier function, and provide substrates necessary for tissue repair. IV fluid therapies with multivitamins integrate to support overall treatment response.

Clinical procedure visualization

Core Therapeutic Benefits

Umbilical cord mesenchymal stem cells and their derivatives offer multiple mechanisms of action in the adjunctive management of atopic dermatitis.

Pruritus & Inflammation Modulation

Reduction of pruritus, erythema, and inflammatory flares through immunomodulatory mechanisms targeting Th2 cytokines.

Skin Barrier Restoration

Supports ECM remodeling, promotes filaggrin and ceramide synthesis, and reinforces skin barrier integrity.

Immunoprivileged & Proliferative

UC-MSCs exhibit immunoprivileged characteristics, reducing alloreactivity while supporting local immune homeostasis.

Mechanistic references: MSC paracrine signaling in inflammatory skin disorders (PubMed) | Systematic review: MSCs for atopic dermatitis (PMC) | Clinical insights (ClinicalTrials.gov)

Key Mechanisms of UC-MSC & Derivatives in Eczema

Anti-inflammatory & Immunomodulatory: Reduces Th2-driven inflammation and pruritus.

Skin Barrier Support: Promotes filaggrin, loricrin, and lipid synthesis.

Angiogenesis & Repair: Supports microcirculation and tissue homeostasis.

Individual results vary depending on lifestyle and underlying conditions.

Your Adjunctive Regenerative Journey: A Practical Guide

Download our comprehensive walkthrough detailing the overall experience: from local travel logistics, lodging, and transportation services to payment methods. The guide also includes technical information on umbilical stem cells and derivatives (exosomes), supportive multivitamin IV fluid therapies, and essential pre- & post-treatment recommendations.

This resource provides objective information about supportive approaches and helps you plan your visit with clarity.

Download the Guide

We respect your privacy. Your information will not be shared.

Ideal Candidate Profile

The integral regenerative medicine approach is designed for individuals with atopic dermatitis who have not achieved satisfactory improvement through conventional therapies alone. Appropriate candidates typically present with moderate-to-severe inflammatory skin conditions where immune dysregulation and barrier dysfunction are contributing factors.

Ideal candidates are generally those with chronic inflammatory patterns who maintain realistic expectations and are committed to participating in the comprehensive supportive protocols that accompany the cellular component of treatment.

Diagnosed atopic dermatitis (moderate to severe)
Chronic inflammatory flares persisting despite conventional management
Inadequate response to topical or systemic immunosuppressants
Absence of active cutaneous infections
Realistic expectations regarding outcomes and timeline
Commitment to participate in supportive physical and nutritional therapies
Absence of contraindications to regenerative procedures

Candidate Evaluation

Comprehensive medical assessment to determine appropriateness for adjunctive regenerative intervention.

Important clinical note: This adjunctive approach is not a replacement for conventional atopic dermatitis treatments. Patients should continue those treatments under the direction of their prescribing physician.

MSC adjunctive therapy for atopic dermatitis is not approved by the U.S. FDA, Mexican COFEPRIS (for this indication), or any other regulatory agency. It is considered an adjunctive, supportive procedure. Costs are discussed only after a consultation.

Professional Clinical Perspective

As medical professionals specializing in regenerative medicine, we approach atopic dermatitis with a commitment to evidence-based practice and patient-centered care. Our integral functional approach recognizes that successful outcomes often require addressing multiple contributing factors simultaneously.

We emphasize transparent communication regarding the current scientific understanding of regenerative techniques, the importance of supportive therapies, and the need for realistic expectations. Each treatment plan is individualized based on comprehensive evaluation, patient history, and specific clinical factors.

Our practice maintains a focus on safety, procedural precision, and thorough follow-up care to monitor progress and adjust supportive therapies as needed throughout the regenerative process.

— Nexus Regenerative Medicine Clinical Team

Medically reviewed by Dr. Guillermo Quezada, MD – May 2026, regenerative medicine specialist. | Content reviewed as of March 2026.